CMKLR1 and Other metabolic disease: Also, inhibiting chemerin’s receptor, ChemR23, with a small molecule, CCX832, might diminish the downstream inflammatory effect, reduce oxidative stress, and worsen insulin signaling in diabetes, suggesting it could be targeted to improve cardiovascular health in metabolic diseases.